Financhill
Back

Okta, Inc. Vs. Monopar Therapeutics, Inc. Industry Stock Comparison

Sell
49

OKTA
Okta, Inc.

Last Price:
$90.24
Seasonality Move:
14.71%
Sell
31

MNPR
Monopar Therapeutics, Inc.

Last Price:
$69.11
Seasonality Move:
25.93%
Sell
49
Okta, Inc. (OKTA) is a Sell

Is Okta, Inc. a Buy, Sell or Hold?

  • The current Okta, Inc. [OKTA] share price is $90.23. The Score for OKTA is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • OKTA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
31
Monopar Therapeutics, Inc. (MNPR) is a Sell

Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Monopar Therapeutics, Inc. [MNPR] share price is $65.99. The Score for MNPR is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

OKTA Stock Price Chart

What is Okta, Inc.'s stock price today?

  • The Okta, Inc. share price today is $90.23
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and OKTA is experiencing slight buying pressure.

MNPR Stock Price Chart

What is Monopar Therapeutics, Inc.'s stock price today?

  • The Monopar Therapeutics, Inc. share price today is $65.99
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight selling pressure.

OKTA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.38 Buy
Relative Strength Index (14 RSI): 60.37 Buy
Chaikin Money Flow: 777567 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (80.31 - 88.63) Buy
Bollinger Bands (100): (84.98 - 93.64) Buy

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.42 Sell
Relative Strength Index (14 RSI): 32.25 Sell
Chaikin Money Flow: -36886 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (73.08 - 86.32) Sell
Bollinger Bands (100): (45.17 - 89.09) Sell

OKTA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 89.48 Buy
20-day SMA: 85.1 Buy
50-day SMA: 86.37 Buy
200-day SMA: 97.39 Sell
8-day EMA: 88.88 Buy
20-day EMA: 86.97 Buy
50-day EMA: 87.09 Buy
200-day EMA: 91.84 Sell

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 73.2 Sell
20-day SMA: 79.37 Sell
50-day SMA: 82.12 Sell
200-day SMA: 52.13 Buy
8-day EMA: 72.25 Sell
20-day EMA: 76.67 Sell
50-day EMA: 77.13 Sell
200-day EMA: 56.56 Buy

Okta, Inc. Earnings Growth & OKTA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.07 per share, an increase this year of $1.29 per share, and an increase next year of $0.66 per share.

Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.

Okta, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Monopar Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):